Bruker Corporation
NMS: BRKRLive Quote
📈 ZcoreAI Score
Our AI model analyzes Bruker Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get BRKR Z-Score →About Bruker Corporation
Healthcare
Medical Devices
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
📊 Fundamental Analysis
Bruker Corporation demonstrates a profit margin of -0.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported -0.2% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -0.4%, which indicates that capital utilization is currently under pressure.
At a current price of $37.59, BRKR currently sits at the 33rd percentile of its 52-week range (Range: $28.53 - $56.22).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$5.72B
Trailing P/E
--
Forward P/E
15.56
Beta (5Y)
1.20
52W High
$56.22
52W Low
$28.53
Avg Volume
2.29M
Day High
Day Low